Additionally, while DDX21-driven genomic instability may enhance chemosensitivity in some cancers, its role in promoting autophagy and survival in others suggests opposing therapeutic implications, underscoring the need for precise, cancer-specific targeting strategies. The gene discussed is DDX21; the disease is cancer.